These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 36098641)
1. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation. Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641 [TBL] [Abstract][Full Text] [Related]
2. Frequency and Characteristics of Nodal and Deltoid FDG and Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000 [No Abstract] [Full Text] [Related]
3. Axillary Lymphadenopathy after COVID-19 Vaccination: Follow-up for Enlarged Lymph Nodes on MR Imaging. Kanemaru N; Yoshikawa T; Miki S; Nakao T; Nakamura Y; Fujimoto K; Abe O Magn Reson Med Sci; 2024 Feb; ():. PubMed ID: 38325833 [TBL] [Abstract][Full Text] [Related]
5. The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccination. Mukai K; Tsunoda H; Imai R; Numata A; Kida K; Oba K; Yagishita K; Yamauchi H; Kanomata N; Kurihara Y Jpn J Radiol; 2023 Jun; 41(6):617-624. PubMed ID: 36626076 [TBL] [Abstract][Full Text] [Related]
7. Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: a single-centre experience in 285 women. Marcon M; Catanese C; Scarano AL; Del Grande F; Manganiello M; Palermo M; Rizzo S Radiol Med; 2023 Oct; 128(10):1217-1224. PubMed ID: 37626156 [TBL] [Abstract][Full Text] [Related]
8. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy. Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849 [TBL] [Abstract][Full Text] [Related]
9. US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study. Ha SM; Chu AJ; Lee J; Kim SY; Lee SH; Yoen H; Cho N; Moon WK; Chang JM Radiology; 2022 Oct; 305(1):46-53. PubMed ID: 35471107 [TBL] [Abstract][Full Text] [Related]
10. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases. Faermann R; Nissan N; Halshtok-Neiman O; Shalmon A; Gotlieb M; Yagil Y; Samoocha D; Friedman E; Sklair-Levy M Acad Radiol; 2021 Sep; 28(9):1191-1197. PubMed ID: 34257025 [TBL] [Abstract][Full Text] [Related]
11. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors. Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425 [No Abstract] [Full Text] [Related]
12. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality. van Nijnatten TJA; Jochelson MS; Lobbes MBI Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513 [TBL] [Abstract][Full Text] [Related]
13. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT. Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Axillary Lymph Nodes on Breast MRI Before and After COVID-19 Booster Vaccination. Parikh R; Feigin KN; Sevilimedu V; Huayanay J; Pinker K; Horvat JV Acad Radiol; 2024 Mar; 31(3):755-760. PubMed ID: 37037711 [TBL] [Abstract][Full Text] [Related]
15. Axillary Lymphadenopathy After Coronavirus Disease 2019 Vaccinations in Patients With Thoracic Malignancy: Incidence, Predisposing Factors, and Imaging Characteristics. Nishino M; Hatabu H; Ricciuti B; Vaz V; Michael K; Awad MM J Thorac Oncol; 2022 Jan; 17(1):154-159. PubMed ID: 34506955 [TBL] [Abstract][Full Text] [Related]
16. Imaging of COVID-19 Vaccine-Related Axillary Lymphadenopathy: Initial Outcomes Based on US Features of Axillary Lymph Nodes. Ahn RW; Porembka JH; Mootz AR; Goudreau SH; Dogan BE; Xi Y; Seiler SJ J Breast Imaging; 2023 Mar; 5(2):135-147. PubMed ID: 38416930 [TBL] [Abstract][Full Text] [Related]
17. Detection of axillary lymphadenopathy after Covid-19 vaccination during breast examination: Case series and review of the literature after one year. Veverková L; Mohelníková-Duchoňová B; Sedláčková Z; Löwová Ľ; Šišola I Cent Eur J Public Health; 2023 Jun; 31(2):110-114. PubMed ID: 37451243 [TBL] [Abstract][Full Text] [Related]
18. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study. Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985 [TBL] [Abstract][Full Text] [Related]
19. Analysis of clinical factors and ultrasound features associated with COVID-19 vaccine-related axillary lymphadenopathy: A large group study. Lim J; Khil EK; Lee SA; Choi JA; Lee KY; Jo SW; Lee J Clin Imaging; 2024 Jan; 105():110046. PubMed ID: 38039749 [TBL] [Abstract][Full Text] [Related]
20. Challenging Axillary Lymph Nodes on PET/CT in Cancer Patients throughout COVID-19 Vaccination Era. Giordano A; Gallicchio R; Milella M; Storto R; Nardelli A; Pellegrino T; Nappi A; Di Cosola M; Storto G Curr Pharm Des; 2024; 30(10):798-806. PubMed ID: 38454762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]